Comparative study on the toxicity of Polygoni Multiflori Radix: Assessment of decoction extract and powder in single-dose and 13-week repeated-dose toxicity studies in Sprague-Dawley rats.

J Ethnopharmacol

Human and Environmental Toxicology, University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon, 34113, Republic of Korea; Department of Advanced Toxicology Research, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon, 34114, Republic of Korea. Electronic address: hankh

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Ethnopharmacological Relevance: Polygoni Multiflori Radix (PMR) is a traditional Chinese herbal medicine widely used for its biological activities. PMR's major components vary by extract form. However, toxicity studies on PMR decoction extract and powder are needed to ensure its safe use.

Aim Of The Study: This study aimed to evaluate the single and repeated administration toxicity studies of PMR decoction extract and powder.

Materials And Methods: Both test items were orally administered to SD rats at doses of 0, 1000, 2000, and 5000 mg/kg for the single-dose, and doses of 0, 313, 625, 1250, 2500, and 5000 mg/kg/day for the 13-week repeated-dose toxicity studies.

Results: The single-dose toxicity study showed no mortality, changes in body weight, clinical signs, or macroscopic findings, with the approximate lethal dose of both test items exceeding 5000 mg/kg. The 13-week repeated-dose toxicity study showed no treatment-related changes in body weight, food consumption, ophthalmology, or macroscopic findings in both test items. In histopathology, stomach hyperplasia occurred at 5000 mg/kg/day in both sexes for PMR decoction extract and in males for PMR powder. Basophilia of tubules was observed in the kidneys of males at 5000 mg/kg/day in the PMR decoction extract group. Therefore, the no observed adverse effect level of PMR decoction extract was set to 2500 mg/kg/day and PMR powder was set to 2500 mg/kg/day for males and exceeded 5000 mg/kg/day for females.

Conclusions: This study establishes the non-toxic doses of PMR decoction extract and powder, determining the non-toxic dose levels based on the different extract forms.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jep.2025.120064DOI Listing

Publication Analysis

Top Keywords

decoction extract
28
pmr decoction
24
extract powder
12
13-week repeated-dose
12
repeated-dose toxicity
12
toxicity studies
12
test items
12
extract
9
pmr
9
polygoni multiflori
8

Similar Publications

Efficacy of extract in amyloid PET-positive patients with mild cognitive impairment.

Front Neurol

August 2025

Department of Neurology, Hyoja Geriatric Hospital, Kuseong-myeon, Yongin-si, Gyeonggi-do, Republic of Korea.

Background: Mild cognitive impairment (MCI) with amyloid PET positivity represents a prodromal stage of Alzheimer's disease (AD), yet no disease-modifying therapies are currently approved. , traditionally used in East Asian and European ethnomedicine as an oral decoction or standardized extract to support memory and cognitive function, is commonly utilized, however, its efficacy as monotherapy in biomarker-confirmed MCI remains uncertain. Aβ oligomers, produced by abnormal cleavage of amyloid precursor protein, disrupt synaptic function and contribute to cognitive decline.

View Article and Find Full Text PDF

Traditional wisdom meets modern science: The protective role of sanhuang shu'ai decoction in ulcerative colitis models.

Phytomedicine

August 2025

Institute of Basic Medicine, North Sichuan Medical College, Nanchong, Sichuan Province, 637100, PR China; Nanchong Key Laboratory of Metabolic Drugs and Biological Products, 55 Dongshun Road, Nanchong, 637100, PR China. Electronic address:

Objective: Despite extensive research on ulcerative colitis (UC), the mechanisms behind its pathogenesis remain incompletely elucidated. Sanhuang Shu'ai decoction (SSD) has granted attention for its potential therapeutic influences in inflammatory conditions, yet the protective mechanisms of SSD in UC models are lacking.

Methods: We investigated the protective effects of SSD extract utilizing two experimental models: lipopolysaccharide (LPS)-induced human colonic organoids and dextran sulfate sodium (DSS)-provoked murine models.

View Article and Find Full Text PDF

Huayu Xiaopi Decoction regulates the JNK/c-Jun/Slug pathway to inhibit epithelial-mesenchymal transformation and improve precancerous lesions of gastric cancer.

J Ethnopharmacol

August 2025

College of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, 750004, China; Ningxia Key Laboratory of Modernization of Minority Medicine, Yinchuan, 750004, China. Electronic address:

Ethnopharmacological Significance: Huayu Xiaopi Decoction (HYXPT), a traditional Chinese medicine formula, exhibits favorable therapeutic effects on precancerous lesions of gastric cancer (PLGC). However, a comprehensive characterization of its chemical constituents and absorbed components remains elusive, and the mechanisms underlying its efficacy in treating PLGC warrant further investigation.

Aim Of The Study: To explore the therapeutic effects and underlying mechanisms of HYXPT in the treatment of PLGC through an integrated approach combining bioinformatics analyses with in vivo and in vitro experiments.

View Article and Find Full Text PDF

Salvia species play a significant role in the pharmaceutical and nutraceutical industries due to their rich chemical profiles and notable biological activities. This study aimed, for the first time, to comprehensively investigate the phytochemical profile and antibacterial properties of eight selected Salvia species. Ethanol and water extracts were prepared from the dried aerial parts, and their chemical compositions were analyzed via LC-HRMS.

View Article and Find Full Text PDF

Monk fruit extract (, MFE) is a natural, non-caloric sweetener known for its intense sweetness, antioxidant properties, and potential metabolic health benefits. While certain aqueous monk fruit decoctions are recognised as non-novel foods in the UK and Ireland due to significant pre-1997 consumption, the European Union (EU) has adopted a more cautious approach under the Novel Food Regulation (EU) 2015/2283. As of October 2024, only one specific aqueous extract of monk fruit has been authorised in the EU under Regulation (EU) 2024/2345, permitting its use in several food categories.

View Article and Find Full Text PDF